Bariatric surgery: a systematic review and meta-analysis.

CONTEXT About 5% of the US population is morbidly obese. This disease remains largely refractory to diet and drug therapy, but generally responds well to bariatric surgery. OBJECTIVE To determine the impact of bariatric surgery on weight loss, operative mortality outcome, and 4 obesity comorbidities (diabetes, hyperlipidemia, hypertension, and obstructive sleep apnea). DATA SOURCES AND STUDY SELECTION Electronic literature search of MEDLINE, Current Contents, and the Cochrane Library databases plus manual reference checks of all articles on bariatric surgery published in the English language between 1990 and 2003. Two levels of screening were used on 2738 citations. DATA EXTRACTION A total of 136 fully extracted studies, which included 91 overlapping patient populations (kin studies), were included for a total of 22,094 patients. Nineteen percent of the patients were men and 72.6% were women, with a mean age of 39 years (range, 16-64 years). Sex was not reported for 1537 patients (8%). The baseline mean body mass index for 16 944 patients was 46.9 (range, 32.3-68.8). DATA SYNTHESIS A random effects model was used in the meta-analysis. The mean (95% confidence interval) percentage of excess weight loss was 61.2% (58.1%-64.4%) for all patients; 47.5% (40.7%-54.2%) for patients who underwent gastric banding; 61.6% (56.7%-66.5%), gastric bypass; 68.2% (61.5%-74.8%), gastroplasty; and 70.1% (66.3%-73.9%), biliopancreatic diversion or duodenal switch. Operative mortality (< or =30 days) in the extracted studies was 0.1% for the purely restrictive procedures, 0.5% for gastric bypass, and 1.1% for biliopancreatic diversion or duodenal switch. Diabetes was completely resolved in 76.8% of patients and resolved or improved in 86.0%. Hyperlipidemia improved in 70% or more of patients. Hypertension was resolved in 61.7% of patients and resolved or improved in 78.5%. Obstructive sleep apnea was resolved in 85.7% of patients and was resolved or improved in 83.6% of patients. CONCLUSIONS Effective weight loss was achieved in morbidly obese patients after undergoing bariatric surgery. A substantial majority of patients with diabetes, hyperlipidemia, hypertension, and obstructive sleep apnea experienced complete resolution or improvement.

[1]  J. Clore,et al.  Diabetes and Hypertension in Severe Obesity and Effects of Gastric Bypass-Induced Weight Loss , 2003, Annals of surgery.

[2]  D. Allison,et al.  Years of life lost due to obesity. , 2003, JAMA.

[3]  C. J. Rosenquist,et al.  Laparoscopic Versus Open Gastric Bypass: A Randomized Study of Outcomes, Quality of Life, and Costs , 2001, Annals of surgery.

[4]  H. Buchwald.  Overview of bariatric surgery. , 2002, Journal of the American College of Surgeons.

[5]  W. Y. Marcus.  Gastrointestinal surgery for severe obesity: a response. , 1992, Maryland medical journal.

[6]  D. Martin,et al.  Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. , 1990, Annals of surgery.

[7]  K. Cianflone,et al.  Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. , 2003, The Journal of clinical endocrinology and metabolism.

[8]  G. Colditz,et al.  The disease burden associated with overweight and obesity. , 1999, JAMA.

[9]  L. Lissner,et al.  Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. , 1999, Obesity research.

[10]  Biliopancreatic Diversion With Duodenal Switch , 2005 .

[11]  C. Buffington,et al.  Significant Changes in Blood Pressure, Glucose, and Lipids with Gastric Bypass Surgery , 1998, World Journal of Surgery.

[12]  A. Mills,et al.  World Health Report 2000: responses to Murray and Frenk , 2001, The Lancet.

[13]  T. Alexandrides,et al.  Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. , 2003, Diabetes.

[14]  E. Frohlich,et al.  Effects of weight reduction on arterial pressure. , 1982, Journal of chronic diseases.

[15]  C. Rand,et al.  Morbidly Obese Patients' Perceptions of Social Discrimination Before and After Surgery for Obesity , 1990, Southern medical journal.

[16]  M. Partinen,et al.  Obstructive sleep apnoea syndrome in morbidly obese patients , 1991, Journal of internal medicine.

[17]  C. Mantzoros,et al.  Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. , 2003, The Journal of clinical endocrinology and metabolism.

[18]  A. Zinsmeister,et al.  Prospective evaluation of vertical banded gastroplasty as the primary operation for morbid obesity. , 1991, Mayo Clinic proceedings.

[19]  D. W. Hess,et al.  Biliopancreatic Diversion with a Duodenal Switch , 1998, Obesity surgery.

[20]  G. Dohm,et al.  A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? , 1998, Annals of surgery.

[21]  D. Cook,et al.  Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions , 1997, Annals of Internal Medicine.

[22]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[23]  M. Thun,et al.  Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years. , 1995, American journal of epidemiology.

[24]  W. Pories,et al.  Etiology of Type II Diabetes Mellitus: Role of the Foregut , 2001, World Journal of Surgery.

[25]  T. A. Hughes,et al.  Significant Changes in the Lipid-Lipoprotein Status of Premenopausal Morbidly Obese Females following Gastric Bypass Surgery , 1994, Obesity surgery.

[26]  S. Simard,et al.  Biliopancreatic Diversion with Duodenal Switch , 1998, World Journal of Surgery.

[27]  I. Kehagias,et al.  Vertical Banded Gastroplasty Versus Standard or Distal Roux-en-Y Gastric Bypass Based on Specific Selection Criteria in the Morbidly Obese: Preliminary Results , 1999, Obesity surgery.

[28]  J. Kral.  The role of surgery in obesity management. , 1995, The International journal of risk & safety in medicine.

[29]  W. Pories,et al.  Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult‐Onset Diabetes Mellitus , 1995, Annals of surgery.

[30]  F. Lönnqvist,et al.  A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding , 2002, International Journal of Obesity.

[31]  E. Adang,et al.  Quality of life assessment of morbidly obese patients: effect of weight-reducing surgery. , 1998, The American journal of clinical nutrition.

[32]  N. Scopinaro,et al.  Biliopancreatic Diversion , 1998, World Journal of Surgery.

[33]  J. Marescaux,et al.  Effect of Duodenal–Jejunal Exclusion in a Non-obese Animal Model of Type 2 Diabetes: A New Perspective for an Old Disease , 2004, Annals of surgery.

[34]  J P Matts,et al.  Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH) , 1990, The New England journal of medicine.

[35]  B. Wansink.  Can Package Size Accelerate Usage Volume? , 1995 .

[36]  B. Rolls,et al.  Increasing the portion size of a packaged snack increases energy intake in men and women , 2004, Appetite.

[37]  M. Murr,et al.  Gastric Bypass is an Effective Treatment for Obstructive Sleep Apnea in Patients with Clinically Significant Obesity , 2003, Obesity surgery.

[38]  E. Minar,et al.  Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[39]  Sherman C. Smith,et al.  Changes in Diabetic Management After Roux-en-Y Gastric Bypass , 1996, Obesity surgery.

[40]  C. Turkelson,et al.  Bariatric Surgery for Morbid Obesity , 2000, Obesity surgery.

[41]  E. Dellinger,et al.  Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. , 2002, The New England journal of medicine.

[42]  M. Sullivan,et al.  Swedish obese subjects (SOS) – an intervention study of obesity. Two-year follow-up of health-related quality of life (HRQL) and eating behavior after gastric surgery for severe obesity , 1998, International Journal of Obesity.

[43]  J. Dixon,et al.  The Laparoscopic Adjustable Gastric Band (Lap-Band®): A Prospective Study of Medium-Term Effects on Weight, Health and Quality of Life , 2002, Obesity surgery.

[44]  R. Sturm.  Increases in clinically severe obesity in the United States, 1986-2000. , 2003, Archives of internal medicine.

[45]  D. Zamir,et al.  Influence of excessive weight loss after gastroplasty for morbid obesity on respiratory muscle performance. , 1998, Thorax.

[46]  R. Cody,et al.  Serum lipids after gastric bypass surgery for morbid obesity. , 1990, International journal of obesity.

[47]  P. Pattyn,et al.  Surgical Treatment of Severe Obesity With a Low-Pressure Adjustable Gastric Band: Experimental Data and Clinical Results in 625 Patients , 2003, Annals of surgery.

[48]  H. Sugerman,et al.  Intra‐abdominal pressure, sagittal abdominal diameter and obesity comorbidity , 1997, Journal of internal medicine.

[49]  J. Hall,et al.  Gastric Surgery for Morbid Obesity: The Adelaide Study , 1990, Annals of surgery.

[50]  A. Mokdad,et al.  The spread of the obesity epidemic in the United States, 1991-1998. , 1999, JAMA.

[51]  J. Alverdy,et al.  Quality of life and psychosocial adjustment in patients after Roux-en-Y gastric bypass: a brief report. , 2001, Obesity surgery.

[52]  H. Buchwald.  A Bariatric Surgery Algorithm , 2002, Obesity surgery.

[53]  Denis Safran,et al.  Laparoscopic Gastric Banding: A Minimally Invasive Surgical Treatment for Morbid Obesity: Prospective Study of 500 Consecutive Patients , 2003, Annals of surgery.

[54]  J. Dixon,et al.  Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment. , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[55]  W. Pories,et al.  Long-term studies of mental health after the Greenville gastric bypass operation for morbid obesity. , 1991, American journal of surgery.

[56]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.

[57]  M. Maxwell,et al.  Obesity and hypertension: long-term effects of weight reduction on blood pressure. , 1985, International journal of obesity.

[58]  M. Carroll,et al.  Overweight and obesity in the United States: prevalence and trends, 1960–1994 , 1998, International Journal of Obesity.

[59]  B. Rolls,et al.  Increased portion size leads to increased energy intake in a restaurant meal. , 2004, Obesity research.

[60]  T. Wadden,et al.  Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. , 2005, Annals of surgery.

[61]  M. Roden,et al.  Ghrelin concentrations in morbidly obese patients after adjustable gastric banding. , 2003, The New England journal of medicine.

[62]  M. Deitel.  Overweight and Obesity Worldwide now Estimated to Involve 1.7 Billion People , 2003, Obesity surgery.

[63]  G. Mingrone,et al.  Sex hormone-binding globulin levels and cardiovascular risk factors in morbidly obese subjects before and after weight reduction induced by diet or malabsorptive surgery. , 2002, Atherosclerosis.

[64]  L. Hedges,et al.  Statistical Methods for Meta-Analysis , 1987 .

[65]  A. Merdad,et al.  A prospective study comparing vertical banded gastroplasty versus laparoscopic adjustable gastric banding in the treatment of morbid and super-obesity. , 1998, International surgery.

[66]  H. Buchwald,et al.  Evolution of Operative Procedures for the Management of Morbid Obesity 1950-2000 , 2002, Obesity surgery.

[67]  J. Gleysteen.  Results of surgery: long-term effects on hyperlipidemia. , 1992, The American journal of clinical nutrition.